MELFI, ROSETTA
 Distribuzione geografica
Continente #
AS - Asia 2.748
NA - Nord America 464
EU - Europa 204
AF - Africa 2
OC - Oceania 2
Totale 3.420
Nazione #
SG - Singapore 2.569
US - Stati Uniti d'America 462
CN - Cina 126
IT - Italia 50
HK - Hong Kong 42
CZ - Repubblica Ceca 41
DE - Germania 40
GB - Regno Unito 27
NL - Olanda 21
FI - Finlandia 7
IN - India 6
FR - Francia 4
LT - Lituania 3
AU - Australia 2
CA - Canada 2
NO - Norvegia 2
SE - Svezia 2
ZA - Sudafrica 2
AL - Albania 1
EE - Estonia 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
LU - Lussemburgo 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UA - Ucraina 1
Totale 3.420
Città #
Ashburn 313
Singapore 55
Hong Kong 40
Boardman 38
Brno 32
Hefei 28
Rome 28
London 25
Munich 23
Shanghai 17
Amsterdam 14
Council Bluffs 13
Olomouc 9
Washington 9
West Jordan 8
Los Angeles 7
San Francisco 6
Bengaluru 4
Hanover 4
Helsinki 4
Xi'an 4
Zhengzhou 4
Dallas 3
Guangzhou 3
Nuremberg 3
Turku 3
Aversa 2
Beijing 2
Bologna 2
Borås 2
Ciampino 2
Durham 2
Hamar 2
Handan 2
Jinan 2
Melbourne 2
Milan 2
New York 2
North Bergen 2
Qingdao 2
Santa Clara 2
Seattle 2
Shenyang 2
Shijiazhuang 2
Xiamen 2
Xiangtan 2
Zhoukou 2
Ankara 1
Anyang 1
Ardea 1
Baoding 1
Bazhou 1
Berlin 1
Bratislava 1
Brooklyn 1
Buffalo 1
Central 1
Centurion 1
Changzhou 1
Chongqing 1
Concord 1
Frankfurt am Main 1
Ganzhou 1
Goodyear 1
Haikou 1
Halfweg 1
Harbin 1
Hohhot 1
Johannesburg 1
Las Vegas 1
Liaocheng 1
Luxembourg 1
Meizhou 1
Milwaukee 1
Mirabella Eclano 1
Nanchang 1
Nanyang 1
Ningbo 1
Oklahoma City 1
Pune 1
Riyadh 1
San Jose 1
Shaoyang 1
Shenzhen 1
Springfield 1
Suzhou 1
Taiyuan 1
Tallinn 1
The Dalles 1
Tirana 1
Topeka 1
Toronto 1
Warsaw 1
Wuhan 1
Yiwu 1
Totale 787
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 402
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 201
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 200
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 192
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 192
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 185
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 185
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 177
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 175
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 160
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation 152
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 145
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 132
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 86
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 85
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 84
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes 80
Correlation between glycemic variability assessed by CGM and short-term outcome in patients undergoing percutaneous coronary intervention 80
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 78
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 77
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 76
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 74
Invasive Assessment of Coronary Microvascular Function 71
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 58
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 31
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 22
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 20
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 18
Totale 3.438
Categoria #
all - tutte 11.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 0 0 0 0 0 0 0 0 1 7 27
2022/202337 2 0 2 8 5 0 1 0 0 0 19 0
2023/2024450 2 9 13 15 10 44 23 258 18 17 7 34
2024/20252.911 39 8 46 20 14 43 32 8 56 134 1.204 1.307
2025/20265 5 0 0 0 0 0 0 0 0 0 0 0
Totale 3.438